Cargando…

Screening for Cognitive Impairment After Stroke: Validation of the Chinese Version of the Quick Mild Cognitive Impairment Screen

Background: Screening for post-stroke cognitive impairment (PSCI) is necessary because stroke increases the incidence of and accelerates premorbid cognitive decline. The Quick Mild Cognitive Impairment (Qmci) screen is a short, reliable and accurate cognitive screening instrument but is not yet vali...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yangfan, Yi, Lingrong, Lin, Yangyang, Peng, Suiying, Wang, Weiming, Lin, Wujian, Chen, Peize, Zhang, Weichao, Deng, Yujie, Guo, Suimin, Shi, Le, Wang, Yuling, Molloy, D. William, O'Caoimh, Rónán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982853/
https://www.ncbi.nlm.nih.gov/pubmed/33763012
http://dx.doi.org/10.3389/fneur.2021.608188
_version_ 1783667809145847808
author Xu, Yangfan
Yi, Lingrong
Lin, Yangyang
Peng, Suiying
Wang, Weiming
Lin, Wujian
Chen, Peize
Zhang, Weichao
Deng, Yujie
Guo, Suimin
Shi, Le
Wang, Yuling
Molloy, D. William
O'Caoimh, Rónán
author_facet Xu, Yangfan
Yi, Lingrong
Lin, Yangyang
Peng, Suiying
Wang, Weiming
Lin, Wujian
Chen, Peize
Zhang, Weichao
Deng, Yujie
Guo, Suimin
Shi, Le
Wang, Yuling
Molloy, D. William
O'Caoimh, Rónán
author_sort Xu, Yangfan
collection PubMed
description Background: Screening for post-stroke cognitive impairment (PSCI) is necessary because stroke increases the incidence of and accelerates premorbid cognitive decline. The Quick Mild Cognitive Impairment (Qmci) screen is a short, reliable and accurate cognitive screening instrument but is not yet validated in PSCI. We compared the diagnostic accuracy of a Chinese version of the Qmci screen (Qmci-CN) compared with the widely-used Chinese versions of the Montreal Cognitive Assessment (MoCA-CN) and Mini-Mental State Examination (MMSE-CN). Methods: We recruited 34 patients who had recovered from a stroke in rehabilitation unit clinics in 2 university hospitals in China: 11 with post-stroke dementia (PSD), 15 with post-stroke cognitive impairment no dementia (PSCIND), and 8 with normal cognition (NC). Classification was made based on clinician assessment supported by a neuropsychological battery, independent of the screening test scores. The Qmci-CN, MoCA-CN, and MMSE-CN screens were administered randomly by a trained rater, blind to the diagnosis. Results: The mean age of the sample was 63 ± 13 years and 61.8% were male. The Qmci-CN had statistically similar diagnostic accuracy in differentiating PSD from NC, an area under the curve (AUC) of 0.94 compared to 0.99 for the MoCA-CN (p = 0.237) and 0.99 for the MMSE-CN (p = 0.293). The Qmci-CN (AUC 0.91), MoCA-CN (AUC 0.94), and MMSE-CN (AUC 0.79) also had statistically similar accuracy in separating PSD from PSCIND. The MoCA-CN more accurately distinguished between PSCIND and normal cognition than the Qmci-CN (p = 0.015). Compared to the MoCA-CN, the administration times of the Qmci-CN (329s vs. 611s, respectively, p < 0.0001) and MMSE-CN (280 vs. 611s, respectively, p < 0.0001) were significantly shorter. Conclusion: The Qmci-CN is accurate in identifying PSD and separating PSD from PSCIND in patients post-stroke following rehabilitation and is comparable to the widely-used MoCA-CN, albeit with a significantly shorter administration time. The Qmci-CN had relatively poor accuracy in identifying PSCIND from NC and hence may lack accuracy for certain subgroups. However, given the small sample size, the study is under-powered to show superiority of one instrument over another. Further study is needed to confirm these findings in a larger sample size and in other settings (countries and languages).
format Online
Article
Text
id pubmed-7982853
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79828532021-03-23 Screening for Cognitive Impairment After Stroke: Validation of the Chinese Version of the Quick Mild Cognitive Impairment Screen Xu, Yangfan Yi, Lingrong Lin, Yangyang Peng, Suiying Wang, Weiming Lin, Wujian Chen, Peize Zhang, Weichao Deng, Yujie Guo, Suimin Shi, Le Wang, Yuling Molloy, D. William O'Caoimh, Rónán Front Neurol Neurology Background: Screening for post-stroke cognitive impairment (PSCI) is necessary because stroke increases the incidence of and accelerates premorbid cognitive decline. The Quick Mild Cognitive Impairment (Qmci) screen is a short, reliable and accurate cognitive screening instrument but is not yet validated in PSCI. We compared the diagnostic accuracy of a Chinese version of the Qmci screen (Qmci-CN) compared with the widely-used Chinese versions of the Montreal Cognitive Assessment (MoCA-CN) and Mini-Mental State Examination (MMSE-CN). Methods: We recruited 34 patients who had recovered from a stroke in rehabilitation unit clinics in 2 university hospitals in China: 11 with post-stroke dementia (PSD), 15 with post-stroke cognitive impairment no dementia (PSCIND), and 8 with normal cognition (NC). Classification was made based on clinician assessment supported by a neuropsychological battery, independent of the screening test scores. The Qmci-CN, MoCA-CN, and MMSE-CN screens were administered randomly by a trained rater, blind to the diagnosis. Results: The mean age of the sample was 63 ± 13 years and 61.8% were male. The Qmci-CN had statistically similar diagnostic accuracy in differentiating PSD from NC, an area under the curve (AUC) of 0.94 compared to 0.99 for the MoCA-CN (p = 0.237) and 0.99 for the MMSE-CN (p = 0.293). The Qmci-CN (AUC 0.91), MoCA-CN (AUC 0.94), and MMSE-CN (AUC 0.79) also had statistically similar accuracy in separating PSD from PSCIND. The MoCA-CN more accurately distinguished between PSCIND and normal cognition than the Qmci-CN (p = 0.015). Compared to the MoCA-CN, the administration times of the Qmci-CN (329s vs. 611s, respectively, p < 0.0001) and MMSE-CN (280 vs. 611s, respectively, p < 0.0001) were significantly shorter. Conclusion: The Qmci-CN is accurate in identifying PSD and separating PSD from PSCIND in patients post-stroke following rehabilitation and is comparable to the widely-used MoCA-CN, albeit with a significantly shorter administration time. The Qmci-CN had relatively poor accuracy in identifying PSCIND from NC and hence may lack accuracy for certain subgroups. However, given the small sample size, the study is under-powered to show superiority of one instrument over another. Further study is needed to confirm these findings in a larger sample size and in other settings (countries and languages). Frontiers Media S.A. 2021-03-05 /pmc/articles/PMC7982853/ /pubmed/33763012 http://dx.doi.org/10.3389/fneur.2021.608188 Text en Copyright © 2021 Xu, Yi, Lin, Peng, Wang, Lin, Chen, Zhang, Deng, Guo, Shi, Wang, Molloy and O'Caoimh. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Xu, Yangfan
Yi, Lingrong
Lin, Yangyang
Peng, Suiying
Wang, Weiming
Lin, Wujian
Chen, Peize
Zhang, Weichao
Deng, Yujie
Guo, Suimin
Shi, Le
Wang, Yuling
Molloy, D. William
O'Caoimh, Rónán
Screening for Cognitive Impairment After Stroke: Validation of the Chinese Version of the Quick Mild Cognitive Impairment Screen
title Screening for Cognitive Impairment After Stroke: Validation of the Chinese Version of the Quick Mild Cognitive Impairment Screen
title_full Screening for Cognitive Impairment After Stroke: Validation of the Chinese Version of the Quick Mild Cognitive Impairment Screen
title_fullStr Screening for Cognitive Impairment After Stroke: Validation of the Chinese Version of the Quick Mild Cognitive Impairment Screen
title_full_unstemmed Screening for Cognitive Impairment After Stroke: Validation of the Chinese Version of the Quick Mild Cognitive Impairment Screen
title_short Screening for Cognitive Impairment After Stroke: Validation of the Chinese Version of the Quick Mild Cognitive Impairment Screen
title_sort screening for cognitive impairment after stroke: validation of the chinese version of the quick mild cognitive impairment screen
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982853/
https://www.ncbi.nlm.nih.gov/pubmed/33763012
http://dx.doi.org/10.3389/fneur.2021.608188
work_keys_str_mv AT xuyangfan screeningforcognitiveimpairmentafterstrokevalidationofthechineseversionofthequickmildcognitiveimpairmentscreen
AT yilingrong screeningforcognitiveimpairmentafterstrokevalidationofthechineseversionofthequickmildcognitiveimpairmentscreen
AT linyangyang screeningforcognitiveimpairmentafterstrokevalidationofthechineseversionofthequickmildcognitiveimpairmentscreen
AT pengsuiying screeningforcognitiveimpairmentafterstrokevalidationofthechineseversionofthequickmildcognitiveimpairmentscreen
AT wangweiming screeningforcognitiveimpairmentafterstrokevalidationofthechineseversionofthequickmildcognitiveimpairmentscreen
AT linwujian screeningforcognitiveimpairmentafterstrokevalidationofthechineseversionofthequickmildcognitiveimpairmentscreen
AT chenpeize screeningforcognitiveimpairmentafterstrokevalidationofthechineseversionofthequickmildcognitiveimpairmentscreen
AT zhangweichao screeningforcognitiveimpairmentafterstrokevalidationofthechineseversionofthequickmildcognitiveimpairmentscreen
AT dengyujie screeningforcognitiveimpairmentafterstrokevalidationofthechineseversionofthequickmildcognitiveimpairmentscreen
AT guosuimin screeningforcognitiveimpairmentafterstrokevalidationofthechineseversionofthequickmildcognitiveimpairmentscreen
AT shile screeningforcognitiveimpairmentafterstrokevalidationofthechineseversionofthequickmildcognitiveimpairmentscreen
AT wangyuling screeningforcognitiveimpairmentafterstrokevalidationofthechineseversionofthequickmildcognitiveimpairmentscreen
AT molloydwilliam screeningforcognitiveimpairmentafterstrokevalidationofthechineseversionofthequickmildcognitiveimpairmentscreen
AT ocaoimhronan screeningforcognitiveimpairmentafterstrokevalidationofthechineseversionofthequickmildcognitiveimpairmentscreen